Mutual Fund Details

ITI Pharma and Healthcare Fund Direct - IDCW Payout

Equity Pharma

NAV

₹14.3249

as on 26 Apr 2024, 11:16 PM

₹0.0227(0.16%)

Last Change

Schemes Managed By

Dhimant Shah

Fund Manager

Rohan Korde

Investment Performance

would have given a return of

₹1,03,499

₹1,06,749

₹1,48,144

₹1,51,229

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹51,229

Profit (absolute return)

51.23%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

7.35%

In the last 6 months

30.12%

In the last 1 year

51.23%

In the last 3 years

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

ITI Pharma and Healthcare Fund Direct - IDCW Payout

as of 31 Mar 2024, 05:30 AM

₹160.39 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 12 months.

0.43%

Expense Ratio

Plan

Dividend

1.88%

Cash Holding

Benchmark

NIFTY Healthcare Total Return Index.

Scheme Document

View

Benchmark

NIFTY Healthcare Total Return Index.

Exit Load

Exit load of 1% if redeemed within 12 months.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

94.49%

₹151.55 Cr

Chemicals

3.63%

₹5.82 Cr

Others

1.88%

₹3.02 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

94.49%

₹151.55 Cr

Chemicals

3.63%

₹5.82 Cr

Others

1.88%

₹3.02 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

16.71%

₹26.80 Cr

Lupin Ltd.

6.00%

₹9.62 Cr

Max Healthcare Institute Ltd.

5.74%

₹9.21 Cr

Dr. Reddy's Laboratories Ltd.

5.38%

₹8.63 Cr

Mankind Pharma Ltd.

5.15%

₹8.26 Cr

Others

61.02%

₹97.87 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

16.71%

₹26.80 Cr

Lupin Ltd.

6.00%

₹9.62 Cr

Max Healthcare Institute Ltd.

5.74%

₹9.21 Cr

Dr. Reddy's Laboratories Ltd.

5.38%

₹8.63 Cr

Mankind Pharma Ltd.

5.15%

₹8.26 Cr

Others

61.02%

₹97.87 Cr

View All

Funds in this Category

This fund's returns:

51.23%

Return Duration

1 Year

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Aditya Birla Sun Life Pharma & Healthcare Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About ITI Pharma and Healthcare Fund Direct - IDCW Payout

ITI Pharma and Healthcare Fund Direct - IDCW Payout is a Equity mutual fund scheme from ITI Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund managers Dhimant Shah and Rohan Korde. It has an AUM of ₹160.39 Crores and the latest NAV decalared is ₹14.325 as on 27 Apr 2024 at 6:02 am.

ITI Pharma and Healthcare Fund Direct - IDCW Payout scheme return performance in last 1 year is 51.23%, is 43.17% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.